WallStSmart
IBO

Impact BioMedical, Inc.

AMEX: IBO · HEALTHCARE · BIOTECHNOLOGY

$0.66
-2.59% today

Updated 2026-05-01

Market cap
$71.16M
P/E ratio
P/S ratio
2,223.81x
EPS (TTM)
$-0.38
Dividend yield
52W range
$0 – $2
Volume
5.4M

Impact BioMedical, Inc. (IBO) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$0.00$50000.00$50000.00$1.03M$2.33M$32000.00
Revenue growth (YoY)+0.0%+1960.0%+126.3%-98.6%
Cost of revenue$0.00$1.57M
Gross profit$50000.00$1.03M$2.33M$-1.54M
Gross margin0.0%100.0%100.0%100.0%-4803.1%
R&D$442302.00$653633.00$63196.00$1.23M$1.69M$91766.00$340000.00
SG&A$176229.00$68850.00$237723.00$383422.00$3.53M$1.05M$1.04M$1.02M$1.95M
Operating income$63952.00$-33861.00$-680025.00$-1.14M$-3.83M$-3.40M$-4.03M$551664.00$-4.27M
Operating margin-7666.1%-6808.0%-391.1%23.7%-13343.8%
EBITDA$63952.00$-33861.00$638.00$-3.76M$-6.30M$-2.84M$-1.54M$-3.13M
EBITDA margin-7526.4%-12602.0%-276.0%-66.0%-9765.6%
EBIT$-97189.00$-205721.00$383.00$-3.83M$-7.41M$-3.96M$-1.88M$-4.27M
Interest expense$15005.00$462000.00$444000.00$168948.00$793000.00
Income tax$59065.00$-104338.00$15005.00$-621000.00$33.00
Effective tax rate0.0%0.0%-11.1%12.1%-0.4%8.1%0.0%-0.0%0.0%
Net income$-408289.00$-98109.00$-590080.00$-760069.00$-3.87M$-7.05M$-4.34M$-2.05M$-11.84M
Net income growth (YoY)+76.0%-501.5%-28.8%-408.8%-82.3%+38.5%+52.7%-477.0%
Profit margin-7734.4%-14102.0%-421.0%-88.0%-36993.8%